Healthcare -
Biotechnology - NASDAQ - US
$ 1.255
-13.8 %
$ 355 M
Market Cap
-1.81
P/E
ERAS - REVENUE
Revenue ERAS - Erasca, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR